Comparing two cyclosporine drops for dry eye over 8 weeks
Treatments studied
Part of Eyes & vision clinical trials.
This study tests whether a newer cyclosporine drop (Vevye) works better than a generic cyclosporine drop for people with dry eye disease. You will use one of the two drops for 8 weeks and have eye exams to see how your symptoms and eye health change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have had dry eye disease in the past 6 months.
- At the first visit, your eye staining scores must be at certain levels (cornea staining score of 3 or higher and conjunctival staining score of 2 or higher).
- You must have a Schirmer test score between 5 and less than 15 mm in 5 minutes without numbing drops in at least one eye.
- Your dry eye discomfort score on a questionnaire must be 35 or higher at the start.
- You have not used any cyclosporine eye drops in the past year, and no other dry eye prescription drops in the past 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
This study tests two types of preservative-free eye drops to see which is more effective for people with mild to moderate dry eye disease. You will use one of the drops as directed, and the study will monitor your symptoms and eye health over time.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.
This study tests a new eye drop formula to see if it safely improves dry eye symptoms. It may be a good option if you have been diagnosed with dry eye and have limited tear production.
This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.
Hear when a new Dry Eye Disease (DED) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.